ight treatment for sleep and circadian disruption in kidney donor patients

Not Applicable

Completed

Conditions: sleep disruption following surgery
Neurological - Studies of the normal brain and nervous system

Registration Number: ACTRN12614000494639

Lead Sponsor: niversity of Auckland

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 40

Inclusion Criteria

Patients must:
a)be scheduled for elective laproscopic nephrectomy surgery at Auckland City Hospital
b) be over 18 years of age.
c) provide written informed consent.

Exclusion Criteria

Patients will be excluded if:
a) they do not meet the inclusion criteria.
b) they are already enrolled in another concurrent clinical trial.
c) A documented sleep condition which they have current active treatment for.
d) At the principal investigator’s discretion.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Sleep disruption (as defined by a combination of total sleep time and sleep fragmentation) will be calculated from actigraphic data using proprietary analysis software (Mini Mitter-Respironics). [All participants will have their sleep monitored (using the non-invasive wrist worn actiwatch devices) for seven days prior to seven and following surgery (total 14-15 days). Actigraphy will be measured using an actiwatch (which is a wrist worn device to monitor sleep wake rhythms and light exposure). <br>Actigraphic data will be analysed at at conclusion of the 14 days of data collection. <br> ]

Secondary Outcome Measures